Latest Alzheimer's news
Lecanemab Reduced Markers of Amyloid in Early Alzheimer Disease
posted December 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Second Death in Trial of Experimental Alzheimer Drug Raising Concerns
posted November 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Telmisartan Linked to Reduced Risk for Alzheimer Disease in Black Patients
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Phosphodiesterase-5 Inhibitors Not Tied to Alzheimer Disease Risk
posted October 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Related Articles
Exercise Link to Dementia Varies by Physical Activity Domain 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy Monthly Specialist Briefings
Stay Connected
